Cargando…

Producer vs. parental cell – metabolic changes and burden upon α(1)-antitrypsin production in AGE1.HN(®)

Detalles Bibliográficos
Autores principales:	Niklas, Jens, Priesnitz, Christian, Sandig, Volker, Rose, Thomas, Heinzle, Elmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285021/ https://www.ncbi.nlm.nih.gov/pubmed/22373391 http://dx.doi.org/10.1186/1753-6561-5-S8-P85

Ejemplares similares

Compartmentation and channelling of metabolites in the human cell line AGE1.HN(®)
por: Niklas, Jens, et al.
Publicado: (2011)

Characterisation of cultivation of the human cell line AGE1.HN.AAT
por: Schräder, Eva, et al.
Publicado: (2011)

Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis
por: Niklas, Jens, et al.
Publicado: (2010)

Analysis of the mitochondrial subproteome of the human cell line AGE1.HN – a contribution to a systems biology approach
por: Schräder, Eva, et al.
Publicado: (2011)

Evaluation of sampling and quenching procedures for the analysis of intracellular metabolites in CHO suspension cells
por: Wahrheit, Judith, et al.
Publicado: (2011)

Characterization of the human AGE1.HN cell line: a systems biology approach
por: Scholz, Sebastian, et al.
Publicado: (2011)

Biosynthetic pathway deflection – a new cell line engineering approach
por: von Horsten, Hans Henning, et al.
Publicado: (2011)

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses
por: Jordan, Ingo, et al.
Publicado: (2011)

Toolbox approach for fast generation of stable CHO production cell lines from different hosts
por: Seitz, Susanne, et al.
Publicado: (2011)

Dysregulated neutrophil function in individuals with alpha-1 antitrypsin deficiency caused by modified membrane cholesterol content.
por: Jundi, Bakr, et al.
Publicado: (2015)

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001)

Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
por: Skriner, K, et al.
Publicado: (2001)

The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
por: Nakanishi, Tomoko, et al.
Publicado: (2020)

DoE of fed-batch processes – model-based design and experimental evaluation
por: Sercinoglu, Onur, et al.
Publicado: (2011)

The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs
por: Wilkens, Marion, et al.
Publicado: (2021)

Leukocyte adhesion and recruitment, and alpha-1-antitrypsin deficiency: a report from ATS 2001, May 18-23, San Francisco
por: Woolhouse, Ian
Publicado: (2001)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews
por: Miravitlles, Marc, et al.
Publicado: (2022)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Physical methods for synchronization of a human production cell line
por: Platas Barradas, Oscar, et al.
Publicado: (2011)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Characterization of the T cell response to hnRNP-A2 (RA33) in HLA-DR4 transgenic mice
por: Hoffmann, M, et al.
Publicado: (2004)

The Cancer Scene in ODA Countries – Cancer Burden vs Resources - Tanzania
por: Makwani, Hellen
Publicado: (2017)

The Cancer Scene in ODA Countries – Cancer Burden vs Resources - Ghana
por: Amankwaa-Frempong, Emmanuel
Publicado: (2017)

The Cancer Scene in ODA Countries – Cancer Burden vs Resources - Jordan
por: Khader, Jamal
Publicado: (2017)

The Cancer Scene in ODA Countries – Cancer Burden vs Resources - Nigeria
por: ARUAH, Simeon Chinedu
Publicado: (2017)

Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Characterization of autoreactive T cells to the autoantigens hnRNP-A2/RA33 and filaggrin in patients with rheumatoid arthritis and controls
por: Fritsch, R, et al.
Publicado: (2001)

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
por: Schett, G, et al.
Publicado: (2003)

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells
por: Lohr, Verena, et al.
Publicado: (2012)

Immune response to hn and snRNP in autoimmune mice. A model for the development of lupus autoimmunity by a single initiator T helper epitope?
por: Monneaux, F, et al.
Publicado: (2001)

Alpha 1-antitrypsin and survival in hepatocellular carcinoma.
por: Tzonou, A., et al.
Publicado: (1990)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Alpha 1-antitrypsin retention in an ectopic liver
por: Dettmer, Matthias, et al.
Publicado: (2011)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
por: Topic, Aleksandra, et al.
Publicado: (2009)

Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma
por: Topic, Aleksandra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q3uia0hgbgj7bohk9u1dj0eri8